IL84529A - Pharmaceutical compositions containing diltiazem and an angiotensin-converting enzyme inhibitor - Google Patents

Pharmaceutical compositions containing diltiazem and an angiotensin-converting enzyme inhibitor

Info

Publication number
IL84529A
IL84529A IL84529A IL8452987A IL84529A IL 84529 A IL84529 A IL 84529A IL 84529 A IL84529 A IL 84529A IL 8452987 A IL8452987 A IL 8452987A IL 84529 A IL84529 A IL 84529A
Authority
IL
Israel
Prior art keywords
angiotensin
pharmaceutical compositions
compositions containing
converting enzyme
enzyme inhibitor
Prior art date
Application number
IL84529A
Other languages
English (en)
Other versions
IL84529A0 (en
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9341007&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL84529(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Synthelabo filed Critical Synthelabo
Publication of IL84529A0 publication Critical patent/IL84529A0/xx
Publication of IL84529A publication Critical patent/IL84529A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Vascular Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL84529A 1986-11-20 1987-11-19 Pharmaceutical compositions containing diltiazem and an angiotensin-converting enzyme inhibitor IL84529A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8616138A FR2607004B1 (fr) 1986-11-20 1986-11-20 Compositions pharmaceutiques contenant du diltiazem et un inhibiteur de l'enzyme de conversion de l'angiotensine

Publications (2)

Publication Number Publication Date
IL84529A0 IL84529A0 (en) 1988-04-29
IL84529A true IL84529A (en) 1992-11-15

Family

ID=9341007

Family Applications (1)

Application Number Title Priority Date Filing Date
IL84529A IL84529A (en) 1986-11-20 1987-11-19 Pharmaceutical compositions containing diltiazem and an angiotensin-converting enzyme inhibitor

Country Status (13)

Country Link
US (1) US4983598A (de)
EP (1) EP0272177B1 (de)
JP (1) JPH0725702B2 (de)
AT (1) ATE54253T1 (de)
AU (1) AU596712B2 (de)
CA (1) CA1302268C (de)
DE (1) DE3763582D1 (de)
DK (1) DK607387A (de)
FR (1) FR2607004B1 (de)
IE (1) IE60594B1 (de)
IL (1) IL84529A (de)
NZ (1) NZ222615A (de)
ZA (1) ZA878675B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3633496A1 (de) * 1986-10-02 1988-04-14 Hoechst Ag Kombination von angiotensin-converting-enzyme-hemmern mit calciumantagonisten sowie deren verwendung in arzneimitteln
US4871731A (en) * 1987-10-07 1989-10-03 Marion Laboratories, Inc. Captopril and diltiazem composition and the like
IL90189A0 (en) * 1988-06-01 1989-12-15 Squibb & Sons Inc Pharmaceutical compositions containing a benzazepine-type calcium channel blocker
IT1226796B (it) * 1988-07-15 1991-02-19 Simes Composizione farmaceutica utile per il trattamento di malattie cardiovascolari.
JP2863534B2 (ja) * 1988-10-24 1999-03-03 マリオン ラボラトリーズ，インコーポレイティド 医薬組成物
US5093129A (en) * 1989-01-30 1992-03-03 E. R. Squibb & Sons, Inc. Method for treating addiction to a drug of abuse employing an ace inhibitor
US5492904A (en) * 1991-05-15 1996-02-20 E. I. Du Pont De Nemours And Company Composition of angiotensin-II receptor antagonists and calcium channel blockers
NZ242724A (en) * 1991-05-15 1994-09-27 Du Pont Synergistic composition comprising an angiotensin-ii receptor antagonist and a calcium channel blocker
TW216770B (de) * 1991-07-23 1993-12-01 Hoffmann La Roche
FR2684553B1 (fr) * 1991-12-10 1995-04-07 Bioprojet Soc Civ Nouveaux medicaments pour le traitement de l'hypertension arterielle, de l'insuffisance cardiaque chronique, de l'insuffisance renale et, de maniere generale, d'affections entrainant une retention hydrosodee.
US6555139B2 (en) 1999-06-28 2003-04-29 Wockhardt Europe Limited Preparation of micron-size pharmaceutical particles by microfluidization
SE9903028D0 (sv) * 1999-08-27 1999-08-27 Astra Ab New use
DK1216038T3 (da) * 1999-08-30 2005-12-27 Sanofi Aventis Deutschland Anvendelse af inhibitorer af reninangiotensinsystemet ved forebyggelsen af cardiovaskulære hændelser
US6569456B2 (en) 2000-01-13 2003-05-27 Osmotica Corp. Osmotic device containing diltiazem and an ACE inhibitor or diuretic
US6635277B2 (en) 2000-04-12 2003-10-21 Wockhardt Limited Composition for pulsatile delivery of diltiazem and process of manufacture
RU2255740C2 (ru) * 2003-07-02 2005-07-10 Научно-исследовательский институт кардиологии Томского научного центра СО РАМН Способ подбора дозы дилтиазема для лечения больных постинфарктным кардиосклерозом с недостаточностью кровообращения 2 функционального класса
US20050032879A1 (en) * 2003-08-07 2005-02-10 Temple Okarter Formulations and use of a beta-blocker and an ACE-inhibitor for the treatment of cardiovascular diseases

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3562257A (en) * 1967-10-28 1971-02-09 Tanabe Seiyaku Co Benzothiazepine derivatives
US4046889A (en) * 1976-02-13 1977-09-06 E. R. Squibb & Sons, Inc. Azetidine-2-carboxylic acid derivatives
WO1985004402A1 (fr) * 1984-03-24 1985-10-10 Takeda Chemical Industries, Ltd. Composes cycliques fusionnes a sept membres et leur procede de preparation
EP0189336A1 (de) * 1985-01-18 1986-07-30 Synthelabo Pharmazeutische Zusammensetzungen mit Gehalt an einem alpha-Blocker und an einem Calcium-Antagonisten
US4694002A (en) * 1986-08-21 1987-09-15 E. R. Squibb & Sons, Inc. Benzothiazepine derivatives
DE3633496A1 (de) * 1986-10-02 1988-04-14 Hoechst Ag Kombination von angiotensin-converting-enzyme-hemmern mit calciumantagonisten sowie deren verwendung in arzneimitteln
US4871731A (en) * 1987-10-07 1989-10-03 Marion Laboratories, Inc. Captopril and diltiazem composition and the like

Also Published As

Publication number Publication date
ZA878675B (en) 1988-07-27
FR2607004B1 (fr) 1990-06-01
US4983598A (en) 1991-01-08
NZ222615A (en) 1989-09-27
DK607387D0 (da) 1987-11-19
IE873123L (en) 1988-05-20
ATE54253T1 (de) 1990-07-15
EP0272177A1 (de) 1988-06-22
JPS63141934A (ja) 1988-06-14
JPH0725702B2 (ja) 1995-03-22
AU596712B2 (en) 1990-05-10
IE60594B1 (en) 1994-07-27
IL84529A0 (en) 1988-04-29
DK607387A (da) 1988-05-21
EP0272177B1 (de) 1990-07-04
DE3763582D1 (de) 1990-08-09
CA1302268C (en) 1992-06-02
FR2607004A1 (fr) 1988-05-27
AU8140787A (en) 1988-05-26

Similar Documents

Publication Publication Date Title
ZA878675B (en) Pharmaceutical compositions containing diltiazem and an enzyme inhibitor
CY2093B1 (en) Dual action inhibitors
EG18081A (en) Combination of angiotensin-converting enzyme inhibitors with calcium antagonists as well as the use indurugs
PH21831A (en) New triphenylmethyl derivatives of sn-glycero-3-phosphocholine and sn-glycero-3-phospho-(n-triphenylmethyl)-ethanolamines
EP0567088A3 (de) Verfahren zur Herstellung eines Amylase-Inhibitors.
AU5896886A (en) Improved process for the removal of H2S from geothermal steam
ZA879296B (en) Enzymatic detergent composition
FR2619608B1 (fr) Manchon d'etancheite, notamment pour joints homocinetiques
AU577831B2 (en) Acylamino oxo or hydroxy substituted alkylamino thiazines andthiazepines
PH22837A (en) Indolophenanthridines
GR862285B (en) Pharmaceutical compositions for treating the high blood pressure
FR2708603B1 (fr) Procédé de préparation d'hydroperoxyde de cumène.
ZA873984B (en) Substituted aminoalkanoylaminoalkyl phosphonate angiotesin converting enzyme inhibitors
AU549234B2 (en) Device for the determination of microorganisms
HUT47328A (en) Sealing arrangement for the upper end of stand-pipe respectively conveying duct
TW239124B (en) Process for the preparation of 2,4,5-tribromopyrrole-3-carbonitrile
GB8916289D0 (en) Cofactor for the pam enzyme
GB2289535B (en) Paracetamol phosphate for immunoassays
ES2065844A1 (es) Aplicacion de ent-16,18-dihidroxi-6-oxo-oxido de manoilo como inhibidor de la adenilatociclasa.
ES2065843A1 (es) Aplicacion de ent-11 , 16-dihidroxi-18-nor-4a -carboximetil-oxido de manoilo como inhibidor de la adenilatociclasa.
YU45012B (en) Process for obtaining inhibitor of 5-lipoxygenaze
GB8917615D0 (en) Part re-usable seal
YU205186A (en) Stifler for fluid blows
BG43934A1 (en) Composition for polysulphidic sealing agents
NO870820D0 (no) Fremgangsmaate for aa uskadeliggjoere problemavfall.

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed